Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant

Cristina Papayannidis, Chiara Sartor, Alida Dominietto, Elisabetta Zappone, Mario Arpinati, Giovanni Marconi, Gianluca Cristiano, Jacopo Nanni, Sarah Parisi, Francesco Barbato, Stefania Paolini, Simona Soverini, Carolina Terragna, Valentina Robustelli, Nicoletta Testoni, Gabriella Chirumbolo, Antonio Curti, Michele Cavo, Francesca Bonifazi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalHematological Oncology
DOIs
Publication statusAccepted/In press - 2021

Keywords

  • acute lymphoblastic leukemia
  • donor lymphocyte infusion
  • inotuzumab Ozogamicin
  • stem cell transplant

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this